This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Gilead Sciences, Inc.. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Innovations of Dong Min Mun in HIV Therapeutics
Introduction
Dong Min Mun is an accomplished inventor based in Newark, CA (US). He has made significant contributions to the field of therapeutic compounds aimed at combating HIV virus infections. With a total of 2 patents to his name, Mun's work is pivotal in the ongoing fight against retroviral diseases.
Latest Patents
Mun's latest patents focus on therapeutic compounds for HIV virus infection. The present disclosure relates generally to certain compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions provided herein may be used for the treatment or prevention of a Retroviridae infection, including an HIV infection.
Career Highlights
Dong Min Mun is currently associated with Gilead Sciences, Inc., a leading biopharmaceutical company known for its innovative research in antiviral therapies. His work at Gilead has allowed him to contribute to groundbreaking advancements in HIV treatment.
Collaborations
Some of his notable coworkers include Julie Farand and Tezcan Guney, who collaborate with him on various research projects aimed at developing effective therapeutic solutions.
Conclusion
Dong Min Mun's innovative work in the field of HIV therapeutics showcases his dedication to improving health outcomes for individuals affected by retroviral infections. His contributions are vital in the ongoing battle against HIV, and his patents reflect a commitment to scientific advancement.